Pacific Biosciences of California, Inc.PACBNASDAQ
Loading
Debt Growth Recovery in ProgressRecovering
Percentile Rank95
3Y CAGR+654.6%
Year-over-Year Change
Year-over-year debt growth rate
3Y CAGR
+654.6%/yr
Quarterly compound
Percentile
P95
Near historical high
vs 3Y Ago
429.6x
Strong expansion
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 8.02% |
| Q3 2025 | 0.55% |
| Q2 2025 | 0.02% |
| Q1 2025 | 3.97% |
| Q4 2024 | -26.97% |
| Q3 2024 | -0.45% |
| Q2 2024 | -0.69% |
| Q1 2024 | -0.27% |
| Q4 2023 | -0.17% |
| Q3 2023 | -0.22% |
| Q2 2023 | -0.76% |
| Q1 2023 | -0.39% |
| Q4 2022 | 0.02% |
| Q3 2022 | -0.20% |
| Q2 2022 | -0.19% |
| Q1 2022 | -0.35% |
| Q4 2021 | 0.25% |
| Q3 2021 | 1.83% |
| Q2 2021 | -0.08% |
| Q1 2021 | 2130.07% |
| Q4 2020 | -2.35% |
| Q3 2020 | -2.17% |
| Q2 2020 | -2.01% |
| Q1 2020 | -27.24% |
| Q4 2019 | -0.91% |
| Q3 2019 | -0.87% |
| Q2 2019 | -0.84% |
| Q1 2019 | 331.95% |
| Q4 2018 | 1.91% |
| Q3 2018 | 1.86% |
| Q2 2018 | 1.79% |
| Q1 2018 | 1.74% |
| Q4 2017 | 2.04% |
| Q3 2017 | 2.13% |
| Q2 2017 | -20.34% |
| Q1 2017 | 1.98% |
| Q4 2016 | 1.98% |
| Q3 2016 | 1.92% |
| Q2 2016 | 1.84% |
| Q1 2016 | 1.79% |